Clinical Trial Details

EORTC-26981-22981

Back to Clinical Trials Database

"Concomitant and adjuvant Temozolomide and Radiotherapy for newly diagnosed glioblastoma multiforme. A randomized phase III study"

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 24-Jul-2000
Date Step1 close: 22-Mar-2002
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 520
Treatment
Study Staff
Type of cancer
Participating groups EORTC Brain Tumor Group
EORTC Radiation Oncology Group
NCIC Clinical Trial Group
Schweizerisches Arbeitsgemeinschaft Klin. Krebsforschung
Trans-Tasman Radiation Oncology Group Inc
Protocol summary http://clinicaltrials.gov/ct/show/NCT00006353
NCT number NCT00006353